{"schema_version":"1","generated_at":"2026-10-30T17:42:01.482Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mina-lobbous","json_url":"https://www.findmykol.com/kol/mina-lobbous/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mina-lobbous","name":"Mina Lobbous","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"city":"Birmingham","state":"AL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1063832046","orcid":"0000-0002-7034-2079","openalex":"A5040985238"},"summary":"Mina Lobbous is a Neurology physician. OpenAlex indexes 115 publications with 382 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":115,"cited_by_count":382,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"SpringWorks Therapeutics, Inc.","program_year":2025,"amount_usd":30495.38,"payment_count":23,"source_url":"https://openpaymentsdata.cms.gov/search?query=1063832046"},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2025,"amount_usd":10425.96,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1063832046"},{"payer":"Monteris Medical Corporation","program_year":2025,"amount_usd":46.32,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1063832046"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1063832046","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results","year":2026,"journal":"Nature Cancer","source_url":"https://doi.org/10.1038/s43018-026-01120-7","status":"verified"},{"title":"Seizure Characteristics Differ Among Grade Four Glioma Subtypes (P3-6.004)","year":2026,"journal":"Neurology","source_url":"https://doi.org/10.1212/wnl.0000000000213034","status":"verified"},{"title":"Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US","year":2025,"journal":"JAMA Neurology","source_url":"https://doi.org/10.1001/jamaneurol.2025.3011","status":"verified"},{"title":"Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib","year":2025,"journal":"JAMA Dermatology","source_url":"https://doi.org/10.1001/jamadermatol.2024.6574","status":"verified"},{"title":"Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastoma","year":2025,"journal":"Neuro-Oncology Advances","source_url":"https://doi.org/10.1093/noajnl/vdaf038","status":"verified"}],"source":"works"},"contact":{"address_1":"619 19TH ST S","city":"Birmingham","state":"AL","zip":"352331900","phone":"205-934-4011","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1063832046","source":"identity"},"similar":[{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":5,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-10-20","provider_certified":"2022-03-07","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}